Echo is the Founder and Chief Executive Officer of MSQ Ventures, a New York-based cross-border advisory firm that bridges the healthcare industry globally by offering deep knowledge and local insight of China’s market. Echo is on a mission to make technology accessible by bridging the gap between western companies and Chinese corporations and investors. Echo is unique in that she has 20 years of experience in cross-border transactions for fortune global companies, such as IBM, Lenovo and J&J. In recent years, making the global movement of the healthcare industry has been Echo’s focus. She has been advising hundreds of western pharmaceutical and medical devices companies on advancing their success in China including subsidiaries of Novartis, Daichi, and other top global healthcare companies.
Echo holds an MBA from Duke University and the FINRA Series , 63 and 79 securities licenses. Echo is currently serving on DukeNY Board.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.